Specifically, the BRA has to be performed taking into consideration the therapeutic context of the assessed drug. The reflection paper also emphasizes the uncertainties and variability of those estimations as well as their influence on the choice. Second, it has an acknowledgment of the necessity to assist exploration in the event of quantitative o